We are live on ! Find out more
LAB icon

Standard BioTools
LAB

84 hedge funds and large institutions have $217M invested in Standard BioTools in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

4% more funds holding

Funds holding: 81 → 84 (+3)

5% more call options, than puts

Call options by funds: $238K | Put options by funds: $227K

0.42% more ownership

Funds ownership: 95.01% → 95.42% (+0.42%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less capital invested

Capital invested by funds: $217M → $217M (-$852K)

Holders
84
Holders Change
+3
Holders Change %
+3.7%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
38
Reduced
18
Closed
9
Calls
$238K
Puts
$227K
Net Calls
+$11K
Net Calls Change
+$28K

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$3.6M
2
Millennium Management
Millennium Management
New York
+$2.45M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.02M
4
SSA
Schonfeld Strategic Advisors
New York
+$982K
5
Renaissance Technologies
Renaissance Technologies
New York
+$965K

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.65M
2
Neuberger Berman Group
Neuberger Berman Group
New York
-$1.47M
3
WA
Wasatch Advisors
Utah
-$1.3M
4
SAM
Silverback Asset Management
North Carolina
-$953K
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$795K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
76
Ameritas Investment Partners
Nebraska
$13K – – –
WAM
77
Wealthspire Advisors (Maryland)
Maryland
$6K -$3.26K -496 -32%
Citigroup
78
Citigroup
New York
$6K -$2.25K -343 -26%
MFW
79
Mosaic Family Wealth
Missouri
$4K – – –
Fifth Third Bancorp
80
Fifth Third Bancorp
Ohio
$3K – – –
RCAG
81
Rehmann Capital Advisory Group
Michigan
$1K +$1K +153 New
TDC
82
Thompson Davis & Co
Virginia
$1K +$1.64K +250 New
WA
83
Wasatch Advisors
Utah
– -$1.3M -221,531 Closed
Ohio Public Employees Retirement System (OPERS)
84
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$269K -45,664 Closed
VF
85
Virtu Financial
New York
– -$80K -13,523 Closed
Citadel Advisors
86
Citadel Advisors
Florida
– -$80.4K -12,244 Closed
Parallax Volatility Advisers
87
Parallax Volatility Advisers
California
– -$31K -5,208 Closed
CL
88
CSS LLC
Illinois
– -$30K -5,080 Closed
UBS Group
89
UBS Group
Switzerland
– -$15.4K -2,341 -98%
DCM
90
Delpha Capital Management
New York
– -$4K -602 Closed
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
– -$1.51K -230 -95%
AG
92
Advisor Group
Arizona
– -$1K -180 Closed
Federated Hermes
93
Federated Hermes
Pennsylvania
– -$1K -27 Closed
1 2 3
4

LAB Hedge Fund Activity: Q1 2018 in Review

84 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2018, worth a combined $217M — down 0.39% from $217M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new LAB positions and 9 closed out — a net gain of 3 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $3.6M. The largest seller was Adage Capital Partners, cutting an estimated $7.65M.

  • 84 institutional investors held Standard BioTools (LAB) as of Q1 2018, up from 81 in Q4 2017.
  • Funds reported $217M of Standard BioTools stock for Q1 2018, down 0.39% quarter-over-quarter.
  • 12 funds opened new Standard BioTools positions in Q1 2018 and 9 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q1 2018 was Levin Capital Strategies, an estimated $3.6M added.
  • The largest Standard BioTools seller in Q1 2018 was Adage Capital Partners, an estimated $7.65M sold.

Based on aggregated 13F filings for Q1 2018.